FDA Adverse Event Injury Summary report: N

PROMUS ELEMENT PLUS EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM

MDR report key: 3912766 · Received July 3, 2014

Report

Report Number
2134265-2014-03788
Event Type
Injury
Date Received
July 3, 2014
Date of Event
June 3, 2014
Report Date
June 5, 2014
Manufacturer
BOSTON SCIENTIFIC - GALWAY
Product Code
NIQ
PMA / PMN Number
P110010
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
WI, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DEVICE IS A COMBINATION PRODUCT. (B)(4). IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION. THE BATCH NUMBER IS UNKNOWN AND THE MANUFACTURING RECORDS FOR THE COMPLAINT DEVICE COULD NOT BE REVIEWED. THE MOST PROBABLE ROOT CAUSE IS OPERATIONAL CONTEXT AS DEVICE PERFORMANCE WAS LIMITED DUE TO ANATOMICAL PROCEDURAL FACTORS. (B)(4).

Description of Event or Problem · 1

(B)(4) CLINICAL TRIAL. IT WAS REPORTED THAT STENT UNDERDEPLOYMENT OCCURRED. IN (B)(6) 2014, POST STUDY INDEX PROCEDURE, THE SUBJECT PRESENTED WITH SQUEEZING CHEST DISCOMFORT WITH DIAPHORESIS AND WAS HOSPITALIZED ON THE SAME DAY. ADMISSION ECG REVEALED ANTEROSEPTAL MYOCARDIAL INFARCTION, ABNORMAL ECG. TROPONIN VALUE WAS FOUND TO BE ELEVATED. THE SUBJECT WAS DIAGNOSED WITH Q-WAVE, ST SEGMENT ELEVATION MYOCARDIAL INFARCTION AND CARDIAC CATHETERIZATION WAS RECOMMENDED. A TOTAL OCCLUSION IN THE NON-TARGET VESSEL PROXIMAL LAD (LEFT ANTERIOR DESCENDING) WAS TREATED WITH BALLOON ANGIOPLASTY FOLLOWED BY PLACEMENT OF A 3.00 X 32 MM PROMUS ELEMENT PLUS DRUG ELUTING STENT. THE STENT WAS POST DILATED USING A 3.50 X 6 MM QUANTUM BALLOON. IVUS WAS PERFORMED WHICH REVEALED THAT THE PROXIMAL PORTION OF THE 3.00 X 32 MM PROMUS DRUG ELUTING STENT WAS UNDER DEPLOYED. THIS UNDER DEPLOYED STENT WAS FURTHER TREATED WITH BALLOON INFLATIONS USING A 5.00 X 6 MM QUANTUM BALLOON. FURTHER DILATATIONS WERE PERFORMED USING A 3.25 X 20 MM QUANTUM BALLOON THROUGHOUT THE STENT. REPEAT ANGIOGRAPHY REVEALED EXCELLENT RESULTS WITH 100% PATENCY THROUGHOUT AND NORMAL FLOW. THE EVENT WAS CONSIDERED RESOLVED WITHOUT RESIDUAL EFFECTS AND THE PATIENT WAS DISCHARGED THREE DAYS POST PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
390518 PROMUS ELEMENT PLUS EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM STENT, CORONARY, DRUG-ELUTING NIQ BOSTON SCIENTIFIC - GALWAY UNK717

Patients

Seq Age Sex Outcome Treatment
1 45 YR